Why is Kwality Pharma falling/rising?

As of 09-Jul, Kwality Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 1,143.75, which reflects a decrease of Rs 36.2 or 3.07%. Today's price summary indicates that the stock has underperformed its sector by 3.27%, with an intraday low of Rs 1,135, marking a drop of 3.81%. Despite a strong long-term performance, with a 126.62% return over the past year, the stock has shown a negative trend in recent days, evidenced by a significant drop in delivery volume by 61.96% against the 5-day average. The company has reported impressive financial metrics, including a 241.51% growth in net profit and a low debt-to-EBITDA ratio of 1.03, but it also faces challenges such as a decline in net sales and operating profit over the past five years.
In the broader market context, the stock's short-term performance has been weaker than the benchmark, with a 1-week return of -1.25% compared to the Sensex's slight gain of 0.15%. This underperformance may reflect investor concerns regarding the company's long-term growth potential, as indicated by the negative trends in net sales and operating profit. Additionally, the lack of domestic mutual fund investment could suggest a lack of confidence among institutional investors, further contributing to the stock's recent decline. Overall, while Kwality Pharmaceuticals has demonstrated strong historical performance, current market dynamics and investor sentiment appear to be weighing on its stock price.